KRYS
Krystal Biotech, Inc. Common Stock
$359.76
1.00%
+3.57
Notify me if price changes either direction
Buy KRYS stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
10.6B
Enterprise value
9.7B
Trailing PE
42.914455
Forward PE
37.901905
PEG Ratio
1.0976197144231
Enterprise to EBITDA
48.702
Enterprise to revenue
22.035
Price to book MRQ
8.2124405
Price to sales TTM
23.9346
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-06-30
Revenue (TTM)
440.5M
EBITDA
204.4M
Diluted EPS TTM
8.3
Total Cash (MRQ)
845.6M
Current ratio (MRQ)
8.318
Operating Cash Flow (TTM)
272.3M
KRYS trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
August 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
